Wednesday, May 18, 2022 5:40:50 PM
Page 10: Excerpts:
May 2,2022:
https://www.sec.gov/Archives/edgar/data/1288478/000119380522000727/sc13d10022002_05022022.htm
The aggregate purchase price of the 21,650,000 Shares beneficially owned by Bigger Capital is approximately $214,784
(average PPS of .00992).
The aggregate purchase price of the 7,000,000 Shares beneficially owned by District 2 CF is approximately $48,200
(average PPS of .006885)
The aggregate purchase price of the 18,303,000 Shares beneficially owned by Mr. Bigger’s IRA is approximately $161,379 (average PPS of .008817)
The aggregate purchase price of the 500,000 Shares beneficially owned by Mr. Schlanger is approximately $4,725
(average PPS of .00945)
Total aggregate cost for the 47,453,000 shares was $429,088.00
Of those 47,453,000 shares 28,460,539 shares were sold as noted below for $2,261,996....a heck of a profit margin, with 18,992,461 remaining to be sold and which were likely sold over the last week or so.
-------------------------------------------------------------------------------------------
NOTES are on page 14 at the end of the filing:
May 9,2022:
https://www.sec.gov/Archives/edgar/data/1288478/000092189522001510/sc13da110022002_05092022.htm
On May 5 and 6, 2022 Bigger Capital Fund, LP sold 1,650,000
shares for an average PPS of .1030 and sold 5,500,000 shares at an average PPS of .0727. Gross proceeds of $569,800.00
On May 5 and 6, 2022 District 2 Capital Fund LP sold 1,694,750 shares at an average PPS of .0819 and sold 2,251,000 shares at .0691. Gross proceeds of $294,344.00
On May 5 and 6, 2022 Michael Bigger’s IRA sold 12,829,234 shares at an average PPS of .0846 and sold 4,535,555 shares at an average PPS of .0689. Gross proceeds of $1,397,852.
All tolled the net gross proceeds for 28,460,539 shares that were sold was $2,261,996.00
To bite the worm of incite is to bite the HOOK of the antagonist . They win .
Recent SYSX News
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 08/30/2023 08:54:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:25:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:37:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/30/2023 08:03:59 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM